Reporting owner · Q3 2026 · CIK 2061851

Fitzpatrick Jennifer: insider trades.

Fitzpatrick Jennifer reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($447K), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
1
Companies
1
Name as filed
Fitzpatrick Jennifer

Companies

CompanyRelationshipTransactions
Sionna Therapeutics, Inc. (SION)Officer · CLO and Head of Program Mgmt.4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-17Sionna Therapeutics, Inc.A28,132$056,265Form 4
2026-09-17Sionna Therapeutics, Inc.A28,133$028,133Form 4
2026-07-06Sionna Therapeutics, Inc.M10,250$6.1110,250Form 4
2026-07-06Sionna Therapeutics, Inc.S10,250$43.60Form 4

Questions

What stock did Fitzpatrick Jennifer buy or sell?

Fitzpatrick Jennifer reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($447K), across 1 company.

Is Fitzpatrick Jennifer the same person as other filers with this name?

This page covers SEC CIK 2061851 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/fitzpatrick-jennifer-2061851.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.